Clinical Trial: Phase II Study of Range and Schedule of rPA Doses

Study Status: Completed
Recruit Status: Completed
Study Type: Interventional




Official Title: A Double-Blind, Parallel-Group Study of the Safety, Tolerability and Immunogenicity of a Range of Doses and Dosing Schedules of Recombinant (rPA Based) Anthrax Vaccine in

Brief Summary: This is a dose ranging study comparing different vaccine schedules of rPA vaccine for anthrax. Safety and the capability to induce an immune response will be evaluated.